Smith & Nephew plc (SNN)
NYSE: SNN · Real-Time Price · USD
30.61
-0.24 (-0.78%)
At close: Jun 5, 2026, 4:00 PM EDT
30.60
-0.01 (-0.03%)
After-hours: Jun 5, 2026, 7:00 PM EDT
Smith & Nephew Employees
Smith & Nephew had 16,988 employees as of December 31, 2025. The number of employees decreased by 1,072 or -5.94% compared to the previous year.
Employees
16,988
Change (1Y)
-1,072
Growth (1Y)
-5.94%
Revenue / Employee
$362,844
Profits / Employee
$36,791
Market Cap
13.10B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 16,988 | -1,072 | -5.94% |
| Dec 31, 2024 | 18,060 | -1,021 | -5.35% |
| Dec 31, 2023 | 19,081 | -13 | -0.07% |
| Dec 31, 2022 | 19,094 | 118 | 0.62% |
| Dec 31, 2021 | 18,976 | 395 | 2.13% |
| Dec 31, 2020 | 18,581 | 551 | 3.06% |
| Dec 31, 2019 | 18,030 | 1,349 | 8.09% |
| Dec 31, 2018 | 16,681 | 348 | 2.13% |
| Dec 31, 2017 | 16,333 | 749 | 4.81% |
| Dec 31, 2016 | 15,584 | 898 | 6.11% |
| Dec 31, 2015 | 14,686 | 1,218 | 9.04% |
| Dec 31, 2014 | 13,468 | 2,432 | 22.04% |
| Dec 31, 2013 | 11,036 | 559 | 5.34% |
| Dec 31, 2012 | 10,477 | -266 | -2.48% |
| Dec 31, 2011 | 10,743 | 571 | 5.61% |
| Dec 31, 2010 | 10,172 | 408 | 4.18% |
| Dec 31, 2009 | 9,764 | 7 | 0.07% |
| Dec 31, 2008 | 9,757 | 567 | 6.17% |
| Dec 31, 2007 | 9,190 | 360 | 4.08% |
| Dec 31, 2006 | 8,830 | 212 | 2.46% |
| Dec 31, 2005 | 8,618 | 752 | 9.56% |
| Dec 31, 2004 | 7,866 | 415 | 5.57% |
| Feb 16, 2003 | 7,451 | -55 | -0.73% |
| Dec 31, 2002 | 7,506 | -420 | -5.30% |
| Dec 31, 2001 | 7,926 | -2,509 | -24.04% |
| Dec 31, 2000 | 10,435 | -778 | -6.94% |
| Dec 31, 1999 | 11,213 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Koninklijke Philips | 65,340 |
| STERIS | 17,937 |
| Zimmer Biomet Holdings | 17,000 |
| Bruker | 11,085 |
| Bio-Rad Laboratories | 7,450 |
| Bio-Rad Laboratories | 7,450 |
| Globus Medical | 6,000 |
| Insulet | 5,400 |
SNN News
- 1 day ago - Smith & Nephew downgraded to Hold from Buy at Kepler Cheuvreux - TheFly
- 1 day ago - Smith & Nephew downgraded to Hold from Buy at Kepler Cheuvreux - TheFly
- 4 days ago - Smith+Nephew launch next generation LEAF™ Patient Monitoring System – an innovative pressure injury prevention platform delivering proven clinical impact - GlobeNewsWire
- 4 days ago - Smith & Nephew (SNN) Joins Goldman Sachs' European Conviction List - GuruFocus
- 4 days ago - Smith & Nephew added to European Conviction List at Goldman Sachs - TheFly
- 9 days ago - Smith & Nephew Slides: Investor presentation - Filings
- 11 days ago - Smith & Nephew price target lowered to 1,550 GBp at Goldman Sachs - TheFly
- 25 days ago - Smith & Nephew price target lowered to $30 from $32 at Canaccord - TheFly